Document is current
Any future updates will be listed below
-
Authors
Torp, Nikolaj https://orcid.org/0000-0002-4378-6256
Israelsen, Mads https://orcid.org/0000-0001-9443-5846
Krag, Aleksander https://orcid.org/0000-0002-9598-4932
- License Information
-
More Information
Article History
Accepted: 8 November 2024
First Online: 5 December 2024
Competing interests
: A.K. has served as speaker for Novo Nordisk, Norgine, Siemens and Nordic Bioscience; participated in advisory boards for Siemens, Boehringer Ingelheim and Novo Nordisk, all outside the submitted work; has received research support from Norgine, Siemens, Nordic Bioscience, Astra and Echosense; and is a board member and co-founder of Evido. N.T. and M.I. declare no competing interests.
